HOLD maintained at $354.71 with hybrid trim triggers; five caution signals block forced additions
HOLD rating maintained at $354.71 with hybrid trim architecture (price $360-366, time 3 sessions/9/17 Fed, momentum MACD -1.0). The 8/25 binding lesson's five stacked caution signals block forced additions. 15-20% defensive trim executed via hybrid triggers captured +0.8% alpha in prior iteration. October 345 puts hedge in place for Fed catalyst. Reassess at 9/17 FOMC and Q3 earnings mid-October; upgrade to Overweight on breakout above $362.06 with confirmation, add on flush to $349-350 with 50 SMA hold.
| Position | Action |
|---|---|
| Price reaches $360-366 zone OR 3 sessions expire OR MACD histogram deteriorates to -1.0 | Execute 15-20% defensive trim via hybrid triggers |
| Five or more stacked caution signals present (MACD bearish cross, price below 10 EMA/VWMA/Bollinger middle, consecutive lower highs) | Block forced starter additions per 8/25 binding lesson |
| Flush to $349-350 with 50 SMA ($350.68) holding | Add position at better entry |
| Breakout above $362.06 with volume and MACD confirmation post-Fed | Upgrade to Overweight |
JPMorgan Chase is a fundamentally compelling long at $354.71, positioned to compound earnings at mid-teens, return $50B+ annually to shareholders, and break out to new highs into Q3 earnings, driven by a 93% probability of no Fed rate cuts in 2026 and record earnings power.
| Indicator | Value | Signal |
|---|---|---|
| 200 SMA | 316.89 | bullish |
| 50 SMA | 350.68 | bullish |
| 10 EMA | 356.42 | bearish |
| RSI (14) | 49.75 | neutral |
| MACD Line | 1.38 | neutral |
| MACD Signal | 2.27 | neutral |
| MACD Histogram | -0.89 | bearish |
| Bollinger Upper | 365.66 | neutral |
| Bollinger Middle | 357.66 | bearish |
| Bollinger Lower | 349.67 | neutral |
| ATR (14) | 6.04 |
This report is AI-generated for informational and educational purposes only and is not investment advice or a recommendation to buy or sell any security. Full disclaimer.
When: 3 sessions from now OR pre-Fed 9/17
Then: Execute defensive trim
Q2 2026 produced record earnings, with adjusted net income of $17.78B even excluding the $4.39B special item — still the highest adjusted NI JPM has ever printed outside special-item boost.
↩ rebuts: “Bear 'special item dependency' argument”
EV: +7.1% to $380+ into Q3 earnings · concedes: Near-term momentum is consolidating — MACD has crossed bearish, price is below 10 EMA, ATR compressed to $6.04; Lower highs in sequence since 2026-08-12 ($365 → $363 → $362 → $358 → $356); VWMA declined from $359.21 → $355.77 over 3 weeks; Stock may pull back 2-3% from current levels
JPM is priced for perfection with consensus macro positioning, questionable earnings quality from a one-time $4.39B boost, deteriorating technical distribution signals, and a stretched 2.67x P/B and 15.2x trailing P/E for a bank growing earnings at only 7% forward vs. its historical 18.3% EPS CAGR — creating asymmetric downside risk into binary catalysts.
EV: -$25 to -$35 (targets $340 and $325-330 vs. entry $355-$360) · concedes: The bull's R:R on the long side (target $380, stop $349, risk $5.71 vs. reward $25.29) is actually decent; JPM's franchise is undeniably elite; The macro setup looks favorable on the surface; Q2 2026's record $17.78B underlying net income is impressive in absolute terms
→ vs conservative: MACD bearish cross and four lower highs represent pullback within confirmed uptrend, not reversal signal; 200 SMA still 11.9% below price
→ vs conservative: Buying December 2026 puts at $340–$345 strikes as portfolio insurance is defensive hedging that reflects distrust in the franchise's 17.79% ROE quality
→ vs conservative: UK windfall tax fear is overblown — even worst-case 5% levy on UK profits is single-digit cents EPS hit on a $5T balance sheet
→ vs neutral: Binary framework of waiting for breakout above 362.06 or flush to 340–345 is market timing dressed as discipline; JPM may never revisit 340 if IPO mandate or strong Q3 earnings gap it up 4% overnight
→ vs neutral: Patience is a virtue only when you have no edge; with this fundamental edge (record franchise, structural NII durability, lowest recession odds in years), sitting on hands is the riskiest move
→ vs aggressive: Risk-reward asymmetry favors buyers — downside is contained to 340 while upside targets 380-plus on NII beat or capital markets re-acceleration
| neutral |
| VWMA (20-day) | 355.77 | bearish |
Support: 349.67 · 350.68 · 353.51 · 354.71 · 344.71 · 340.54 | Resistance: 356.42 · 357.66 · 362.06 · 365.18 · 365.66
JPM is consolidating near recent highs after a powerful summer rally, with the critical $349.50–$350.70 zone (50 SMA / lower Bollinger Band confluence) serving as the key level to watch—holding suggests a healthy pullback, while breakdown targets $344–$340. Short-term momentum is bearish (MACD bearish cross, negative histogram, price below 10 EMA and VWMA), but the long-term trend remains firmly bullish with price 11.9% above the 200 SMA.
Market Cap
$942.9B
Price
~$354.80
52-Week Range
$279.10 – $366.50
50-Day Moving Avg
$350.26
200-Day Moving Avg
$318.61
Beta
0.975
P/E (TTM)
15.20x
Forward P/E
14.18x
PEG Ratio
1.67
Price/Book
2.67x
Book Value/Share
$133.01
EPS (TTM)
$23.33
Forward EPS
$25.01
Dividend Yield
1.70%
Net Income (TTM)
$63.63B
Q2 2026 Net Income
$21.16B
Q2 2026 EPS
$7.70
Diluted EPS (2025)
$20.02
Revenue (TTM)
$186.33B
Q2 2026 Revenue
$52.85B
NII (Q2 2026)
$25.51B
Total Assets
$5,015.1B
Net Loans
$1,516.3B
Common Stock Equity
$353.6B
Tangible Book Value
$289.3B
Total Debt
$533.0B
Net Debt
$223.1B
ROE
17.79%
ROA
1.36%
Profit Margin
34.92%
Operating Margin
50.39%
Buybacks (2025)
$34.59B
Dividends (2025)
$16.63B
Total Returned (2025)
$51.22B
Special Income Item (Q2 2026)
$4.39B
Revenue CAGR (4Y)
12.4%
Net Income CAGR (4Y)
14.8%
EPS CAGR (4Y)
18.3%
Assets CAGR (4Y)
6.5%
TBV CAGR (4Y)
10.8%
Strengths
Concerns
JPMorgan Chase delivered record Q2 2026 earnings with $21.16B net income and $7.70 EPS, fueled by 10% YoY NII growth and a $4.39B special income item. The bank has compounded EPS at 18.3% annually since 2022 while returning $51B+ yearly to shareholders, maintaining best-in-class 17.79% ROE. However, shares trade near 52-week highs at a 2.67x P/B premium, and the $4.39B special item and surging net debt ($223B) warrant close monitoring of earnings sustainability and credit quality.
Macro: No-cuts regime anchored by 93% Polymarket probability; 8% recession odds declining; tariff regime keeps duty payments elevated above 2024 norms; $100 oil returns with bond supply stress despite $6bn Treasury intervention; steeper-for-longer rates structurally supportive of NII but constrain capital-markets fee reflation.